Being flexible, embracing technology and making more coordinated efforts to service providers and patients are all lessons that drug manufacturers and patient assistance programs (PAPs) can take from the COVID-19 pandemic, according to a panel of experts at Informa’s PAP Critical Update 2021 virtual event.
Despite it being a difficult year, there were some positive notes to draw from, said Tommy Bramley, PhD, the president of the Lash Group, a patient support services division